1. Introduction {#sec0005}
===============

Viruses are important etiological agents of diarrhea in domestic and wild canids. Among them, canine parvovirus (CPV), a member of the family *Parvoviridae*, is a major cause of hemorrhagic gastroenteritis in dogs ([@bib0040], [@bib0130]). CPV are small, nonenveloped viruses consisting of a single-stranded, negative sense DNA (∼5.2 kb) molecule ([@bib0005], [@bib0150], [@bib0170]). The CPV genome contains two large open reading frames (ORF). The right ORF encodes 2 structural proteins (VP1 and VP2) by alternative splicing of the same mRNAs, whilst the left ORF codes for 2 nonstructural proteins (NS1 and NS2). The CPV VP2 capsid protein is antigenically significant, and has been implicated in governing host range restriction, tropism, and viral-host interactions ([@bib0040], [@bib0130], [@bib0150]).

Most studies on molecular epidemiology of CPV are based on the VP2-encoding gene ([@bib0040], [@bib0130], [@bib0180]). CPV emerged as a new enteric pathogen of domestic dogs in the late 1970s, possibly through host switching events involving a feline panleukopenia parvovirus, or a closely related virus ([@bib0005], [@bib0150]). As a result of accumulation of mutations in the VP2- encoding gene, the original CPV strain (strain CPV-2) eventually got replaced with antigenic variants CPV-2a, CPV-2b, CPV-2c, new CPV-2a, and new CPV-2b that are variously distributed in dog populations worldwide ([@bib0040], [@bib0130]).

Although the current CPV vaccines, derived from the original CPV-2 strains, or CPV-2b strains, have been shown to confer protective immunity against CPV disease, and post-vaccination reactions have rarely been encountered in immunized dogs, the emergence of new genetic and antigenic variants underscores the importance of constant monitoring of evolution patterns of CPV strains circulating in dogs throughout the world ([@bib0040], [@bib0130]).

Canine coronavirus (CCoV) (family *Coronaviridae*, genus *Alphacoronavirus*, species *Alphacoronavirus-I*) usually cause mild, self-limiting enteritis in dogs, although fatal disease has been observed with a pantropic variant of CCoV ([@bib0030], [@bib0035], [@bib0075], [@bib0160]). CCoV are enveloped viruses with a single-stranded, positive sense RNA (27--31 kb) genome ([@bib0030]). The CCoV membrane (M) protein is the most abundant structural protein and has been shown to elicit antibodies, whilst the spike (S) glycoprotein is the main inducer of virus-neutralizing antibodies.

Based on analysis of the M- and/or S- protein encoding genes, CCoV strains have been classified into at least two genotypes, CCoV-I and CCoV-II ([@bib0030], [@bib0035]). Recently, CCoV-II strains were further classified into two subtypes, CCoV-IIa (classical strains) and CCoV-IIb (strains arising from putative recombination events between CCoV-II and transmissible gastroenteritis virus of swine) ([@bib0030], [@bib0035], [@bib0110]). CCoVs have been detected in canine populations worldwide ([@bib0030], [@bib0035]).

The Caribbean region has a sizeable dog population, and dogs with diarrhea, including those with hemorrhagic gastroenteritis are routinely presented at veterinary clinics on these islands. Although the prevalence and genetic diversity of CPV and CCoV in dogs have been extensively studied in different parts of the world including nearby Latin American countries, there are no reports on these important canine viruses from the Caribbean region so far. We report here the detection and molecular characterization of CPV and CCoV strains in dogs with diarrhea on the Caribbean island of St. Kitts (KNA).

2. Materials and methods {#sec0010}
========================

2.1. Sampling {#sec0015}
-------------

During 2015--2016, a total of 104 diarrheic fecal samples were collected from puppies and adult dogs, with or without hemorrhagic gastroenteritis, at two veterinary clinics (the Ross University School of Veterinary Medicine Clinic, and the Ponds Veterinary Clinic) on the island of St. Kitts, Caribbean region. The samples were stored at −20 °C until further analysis. The present study was conducted in compliance with good laboratory practice (GLP).

2.2. Amplification of VP2 gene of CPV {#sec0020}
-------------------------------------

For PCR, viral DNA was extracted from the fecal samples using the QIAamp Fast DNA Stool Mini Kit (Qiagen Sciences, MD, USA). Samples were screened for the presence of CPV using a PCR-based detection assay targeting a 583-bp stretch of the 3′- portion of the VP2-encoding gene, as described previously ([@bib0010]). In order to determine the CPV variant, a 1799 bp fragment of CPV genome containing the complete ORF of VP2 gene was amplified using a newly designed primer VP2F (5′-ATG AGT GAT GGA GCA GTT CAA CC-3′, corresponding to nucleotide \[nt\] 2787-nt 2809 of reference strain CPV-b), and primer *555rev* ([@bib0010]). PCRs were performed using Platinum™ Taq DNA Polymerase (Invitrogen, CA, USA) following manufacturer's instructions. PCR-grade water was used as the negative control.

2.3. Amplification of M-protein encoding gene of CCoV {#sec0025}
-----------------------------------------------------

Viral RNA was extracted from fecal samples using the QIAamp Viral RNA Mini Kit (Qiagen Sciences, MD, USA). For detection of CCoVs in fecal samples, RT-PCR based on a partial stretch (409 bp) of M protein-encoding gene was performed as reported previously ([@bib0165]). RT-PCRs were carried out using SuperScript^®^ III RT (Invitrogen, CA, USA) and Platinum™ Taq DNA Polymerase (Invitrogen, CA, USA) following manufacturers' instructions. We used PCR-grade water as the negative control.

2.4. Nucleotide sequencing {#sec0030}
--------------------------

For nt sequencing, PCR products were purified using the QIAquick PCR Purification Kit (Qiagen Sciences, MD, USA) according to manufacturer's protocol. Nucleotide sequences were obtained using the ABI Prism Big Dye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems, CA, USA) on an ABI Prism 3130 Genetic Analyzer (Applied Biosystems, CA, USA.). The PCR products were sequenced in both directions.

2.5. Sequence analysis {#sec0035}
----------------------

Homology search for related cognate sequences was performed using standard nt BLAST program (Basic Local Alignment Search Tool, [www.ncbi.nlm.nih.gov/blastn](http://www.ncbi.nlm.nih.gov/blastn){#intr0005}). Multiple alignments of deduced amino acid (aa) sequences were performed using the CLUSTALW program (version ddbj, <http://clustalw.ddbj.nig.ac.jp/>) with default parameters. Phylogenetic trees were constructed using the MEGA (v5.2.2) software.

2.6. Nucleotide sequence accession numbers {#sec0040}
------------------------------------------

The GenBank accession numbers for nt sequences of complete, or partial ORF of VP2 genes of the KNA CPV strains, and partial M-protein encoding genes of the KNA CCoV strains are shown in [Table 1](#tbl0005){ref-type="table"} .Table 1Sampling dates, breed, age, and vaccination status of dogs that tested positive for canine parvovirus (CPV), or canine enteric coronavirus (CCoV) on the Caribbean island of St. Kitts (KNA). The GenBank accession numbers, and genotype nature of the CPV and CCoV strains are also shown.Table 1VirusNo.StrainSampling dateBreedAgeVariantVaccination status against CPV[a](#tblfn0005){ref-type="table-fn"}Gene analyzedGenBank accession no.CPV1RVC6/KNAFeb 2015Island mix[b](#tblfn0010){ref-type="table-fn"}1month 1 weekNew CPV-2a[c](#tblfn0015){ref-type="table-fn"}NoneVP2, complete ORF[d](#tblfn0020){ref-type="table-fn"}KY3990332RVC11/KNAJune 2015Mixed breed3 monthsNew CPV−2aNoneVP2, complete ORFKY3990343RVC15/KNAJune 2015Dachshund1 month 2weeks--NoneNot sequenced--4PVC6/KNAJune 2015Pit bull6 monthsNew CPV−2aNot availableVP2, complete ORFKY3990355PVC8/KNAJune 2015Rottweiler x Mastiff5 monthsNew CPV−2aNot availableVP2, complete ORFKY3990366RVC17/KNAJuly 2015Island mixAdult[e](#tblfn0025){ref-type="table-fn"}New CPV−2aNoneVP2, complete ORFKY3990377RVC20/KNAJuly 2015Island mix5 monthsNew CPV−2aNoneVP2, complete ORFKY3990388RVC21/KNAJuly 2015Island mix5 monthsNew CPV−2aNoneVP2, complete ORFKY3990399PVC11a/KNAJuly 2015Mastiff mix3 monthsNew CPV−2aNot availableVP2, complete ORFKY39904010PVC12/KNAJuly 2015Island mix2 monthsNew CPV−2aNot availableVP2, complete ORFKY39904111PVC13/KNAJuly 2015Island mix2 monthsNew CPV−2aNot availableVP2, complete ORFKY39904212RVC23/KNAAug 2015Mixed breed2 yearsNew CPV−2aNoneVP2, complete ORFKY39904313RVC26/KNAAug 2015Mastiff mix6 monthsNew CPV−2aNoneVP2, complete ORFKY39904414RVC43/KNAApr 2016Island mix1 month 3 weeksNew CPV−2a02−2016[f](#tblfn0030){ref-type="table-fn"}VP2, complete ORFKY39904515RVC44/KNAApr 2016Island mix1 yearNew CPV−2a06−2015, 07−2015[f](#tblfn0030){ref-type="table-fn"}VP2, complete ORFKY39904616PVC18/KNAApr 2016Island mix1 year−[g](#tblfn0035){ref-type="table-fn"}Not availableVP2, partial ORFKY39904717PVC21/KNAApr 2016Island mix3 years−[g](#tblfn0035){ref-type="table-fn"}Not availableVP2, partial ORFKY39904818PVC28/KNAMay 2016Island mix1 year--Not availableNot sequenced--19RVC49/KNAJune 2016Mastiff mix2 monthsNew CPV−2aNoneVP2, complete ORFKY39904920RVC50/KNAJune 2016Pit bull mix6 monthsNew CPV−2aNoneVP2, complete ORFKY39905021RVC53/KNAJuly 2016Rottweiler4 months 3 weeksNew CPV−2a05−2016[f](#tblfn0030){ref-type="table-fn"}VP2, complete ORFKY93347922RVC54/KNAJuly 2016Pit bull mix3 monthsNew CPV−2aNoneVP2, complete ORFKY39905123RVC55/KNAJuly 2016Island mix3 monthsNew CPV−2aNoneVP2, complete ORFKY39905224RVC57/KNAAug 2016Island mix3 daysNew CPV−2aNoneVP2, complete ORFKY39905325RVC60/KNAAug 2016Mixed breed1 year 8 months--12--2015[f](#tblfn0030){ref-type="table-fn"}Not sequenced--  CCoV1RVC5/KNAFeb 2015Malinois1 year 5 monthsCCoV-INot applicableM, partial ORFKY9334802RVC 8/KNAJune 2015Mixed breed6 monthsCCoV-INot applicableM, partial ORFKY3990543PVC5/KNAJune 2015Island mix3 monthsCCoV-INot applicableM, partial ORFKY3990554PVC10/KNAJune 2015Pit bull1 month 1 weekCCoV-INot applicableM, partial ORFKY3990565RVC41/KNAFeb 2016Mixed breed2 months 1 week--Not applicableNot sequenced--[^1][^2][^3][^4][^5][^6][^7]

3. Results and discussion {#sec0045}
=========================

The federation of St. Kitts and Nevis is a twin island nation in the Lesser Antilles of the Caribbean region with a total human population of ∼55,000 (Map is shown in Supplementary Fig. S1). Although there are no official estimates on the canine population of St. Kitts, different breeds of domestic dogs, including a local island breed are kept as pets in many households on the island. Diarrhea, including hemorrhagic gastroenteritis is prevalent in domestic dogs on St. Kitts, as evident from clinical cases that are presented now and then at the two major veterinary clinics (the Ross University School of Veterinary Medicine Clinic \[RVC\], and the Ponds Veterinary Clinic \[PVC\]) on the island. In the present study, CPV, or CCoV were detected in 30 (28.8%) of the 104 fecal samples obtained from diarrheic dogs at the two veterinary clinics on St. Kitts ([Table 1](#tbl0005){ref-type="table"}).

3.1. Canine parvovirus {#sec0050}
----------------------

By PCR of the partial VP2 gene, a total of 25 (24%, n = 104) dogs tested positive for CPV. Among them, 15 dogs were presented with hemorrhagic gastroenteritis, whilst the remaining 10 dogs had severe diarrhea. All the CPV positive dogs were sporadic cases from different households across the island of St. Kitts. The age of the dogs that tested positive for CPV ranged from 3 days up to 3 years of age ([Table 1](#tbl0005){ref-type="table"}). Eighteen of the 25 CPV positive dogs were aged ≤ 6 months, corroborating previous observations that dogs up to 6 months may exhibit a greater risk of infection ([@bib0040], [@bib0135]). Most of the CPV positive samples were from mixed breeds ([Table 1](#tbl0005){ref-type="table"}), contradicting a previous observation that purebreds were more susceptible to CPV disease than mixed breeds ([@bib0100]). However, a few other studies have shown that breed may not be a risk factor ([@bib0135]).

Vaccination is crucial to control and prevent CPV disease ([@bib0040], [@bib0130]). Lack of vaccination, incomplete vaccination schedules, or vaccine failures, primarily due to interference with maternal antibodies may predispose dogs to natural infection. Moreover, some studies have raised questions on the complete efficacy of the current CPV vaccines against the CPV antigenic variants, as these vaccines were derived from old CPV-2 strains ([@bib0055], [@bib0060], [@bib0040], [@bib0130], [@bib0180]). In the present study, nearly half (11/25) of the CPV positive dogs did not receive any vaccine, whilst 2 puppies did not attain the recommended minimum age of vaccination (6 weeks) at the time of sampling ([Table 1](#tbl0005){ref-type="table"}). Among the vaccinated dogs that tested positive for CPV (4/25), only one animal had received two doses of the vaccine ([Table 1](#tbl0005){ref-type="table"}). Therefore, lack of, or inadequate protective immunity might have predisposed these dogs to CPV disease, although the role/s of other risk factors, such as endoparasitism and unsanitary environments cannot be ruled out ([@bib0135]). On the other hand, no information was available on the immunization status of the remaining CPV positive dogs ([Table 1](#tbl0005){ref-type="table"}). Information on vaccination status was available for only 26 of the 79 dogs that tested negative for CPV. Eleven of these dogs received one, or more doses of CPV vaccine before sampling, whilst 15 were not immunized against CPV.

To study the genotype nature and evolution of CPV strains circulating in St. Kitts, we determined the complete ORF nt sequences of VP2 genes of 20 KNA strains ([Table 1](#tbl0005){ref-type="table"}). The deduced VP2 aa sequences of all the 20 KNA CPV strains exhibited 297-A, 426-N and 555-V, and therefore, were classified as new CPV-2a (CPV-2a-297A) strains ([Table 2](#tbl0010){ref-type="table"} ; Supplementary Fig. S2). On the other hand, the VP2 genes of the remaining 5 KNA strains were partially characterized, or could not be sequenced due to insufficient volumes of fecal samples ([Table 1](#tbl0005){ref-type="table"}). Other relevant mutations that may influence viral antigenicity and/or host range have also been reported in many of the recent CPV-2a/2b strains, such as G300D, Y324I and T440A ([@bib0040], [@bib0130]). However, these mutations were not observed in the putative VP2 proteins of the KNA new CPV-2a strains ([Table 2](#tbl0010){ref-type="table"}, Supplementary Fig. S2).Table 2Comparison of evolutionary relevant amino acid (aa) residues of putative VP2 proteins of canine parvovirus (CPV) strains detected on the island of St. Kitts (KNA), Caribbean region, with those of CPV-2, CPV-2a, CPV-2b, CPV-2c, new CPV-2a, new CPV-2b, and vaccine strains. The KNA CPV strains are underlined. A dot '.' indicates an identical amino acid residue at cognate position of deduced VP2 aa sequence of the concerned CPV strain with that of reference strain CPV-b/USA/1978. Alignment of complete deduced aa sequences of putative VP2 proteins of the CPV strains is shown in supplementary Fig. S2.Table 2 Amino acid position[a](#tblfn0040){ref-type="table-fn"}808793101103232267297[b](#tblfn0045){ref-type="table-fn"}300305321323324375426[c](#tblfn0050){ref-type="table-fn"}440555560564568570VariantStrainCPV-b/USA/1978RMNIAIFSADNNYNNTVNSGKCPV-2CPV-15/USA/1984.L.T\....GY\...DN.I\....CPV-2aCPV-39/USA/1984.L.T\....GY\...DD\...\...CPV-2b219/08-13/ITA/2008.L.T\...AGY\...DE\...\...CPV−2cCPV-435/USA/2003.L.T\...AGY\...D\...\....New CPV−2aPome/KOR/2005.L.T\...AD[d](#tblfn0055){ref-type="table-fn"}Y\...D.A\.....New CPV−2a[d](#tblfn0055){ref-type="table-fn"}Uy-243/URY/2010.L.T..YAGY..ID.A\.....New CPV−2aCPV-436/USA/2003.L.T\...AGY\...DD\...\...New CPV−2b  [PVC6/KNA/2015]{.ul}.L.T\...AGY\...D\...\....New CPV−2a[PVC8/KNA/2015]{.ul}.L.T\...AGY\...D\...\....New CPV−2a[PVC11a/KNA/2015]{.ul}.L.T\...AGY\...D\...\....New CPV−2a[PVC12/KNA/2015]{.ul}.L.T\...AGY\...D\...\....New CPV−2a[PVC13/KNA/2015]{.ul}.L.T\...AGY\...D\...\....New CPV−2a[RVC6/KNA/2015]{.ul}.L.T\...AGY\...D\...\....New CPV−2a[RVC11/KNA/2015]{.ul}.L.T\...AGY\...D\...\....New CPV−2a[RVC17/KNA/2015]{.ul}.L.T\...AGY\...D\...\....New CPV−2a[RVC20/KNA/2015]{.ul}.L.T\...AGY\...D\...\....New CPV−2a[RVC21/KNA/2015]{.ul}.L.T\...AGY\...D\...\....New CPV−2a[RVC23/KNA/2015]{.ul}.L.T\...AGY\...D\...\....New CPV−2a[RVC26/KNA/2015]{.ul}.L.T\...AGY\...D\...\....New CPV−2a[RVC43/KNA/2016]{.ul}.L.T\...AGY\...D\...\....New CPV−2a[RVC44/KNA/2016]{.ul}.L.T\...AGY\...D\...\....New CPV−2a[RVC49/KNA/2016]{.ul}.L.T\...AGY\...D\...\....New CPV−2a[RVC50/KNA/2016]{.ul}.L.T\...AGY\...D\...\....New CPV−2a[RVC53/KNA/2016]{.ul}.L.T\...AGY\...D\...\....New CPV−2a[RVC54/KNA/2016]{.ul}.L.T\...AGY\...D\...\....New CPV−2a[RVC55/KNA/2016]{.ul}.L.T\...AGY\...D\...\....New CPV-2a[RVC57/KNA/2016]{.ul}.L.T\...AGY\...D\...\....New CPV-2a--Vaccine VANGUARD\...\...\...\....E\...\....CPV-2Vaccine (Duramune) strain SAH.L.T\...AGYK..DD\.....ENew CPV−2b[^8][^9][^10][^11]

The VP2 of KNA CPV strains shared 99--100% nt and deduced aa identities among themselves, and with those of other new CPV-2a strains. Nucleotide and deduced aa identities of 99% were also observed with the VP2 of the CPV-2, CPV-2a, CPV-2b, new CPV-2b, and CPV-2c strains. By phylogenetic analysis of complete ORF nt sequences of VP2 genes, the KNA strains clustered together, and were found to be more closely related to new CPV-2a strains than other CPV-2 variants ([Fig. 1](#fig0005){ref-type="fig"} ), corroborating the observations at deduced aa level.Fig 1Phylogenetic analysis of the complete ORF nucleotide sequences of VP2 genes of St. Kitts (KNA) CPV strains with those of CPV-2, CPV-2a, CPV-2b, CPV-2c, new CPV−2a, new CPV-2b, and vaccine strains. Feline parvovirus (FPV) strain CU-4 clustered as the outgroup. The phylogenetic tree was created by the Maximum Likelihood (ML) method, and statistically supported by bootstrapping with 1000 replicates. Phylogenetic distances were measured by the Tamura-3-parameter model. The clustering patterns of KNA CPV strains were validated by constructing ML trees with other models, such as the Jukes--Cantor model, Kimura 2-parameter model, and Hasegawa--Kishino--Yano model (data not shown). In the tree, positions of the KNA CPV strains are highlighted with dark circles. GenBank accession numbers are shown in parentheses. Bootstrap values \<70% are not shown. Scale bar, 0.005 substitutions per nucleotide.Fig 1

Although the present study is the first report on CPV variants from the Caribbean region, the molecular epidemiology of CPV has been documented in nearby North and South American countries ([@bib0130]). In Ecuador and USA, CPV-2b and CPV-2c were more prevalent than CPV-2a. Only CPV-2c strains have been reported from Mexico and Paraguay. CPV-2c was the major variant in Argentina and Brazil ([@bib0015], [@bib0155]). CPV-2b was the major genotype in Canada ([@bib0090]). In Uruguay, CPV-2c was the predominant variant during 2006--2010 ([@bib0130]). However, new CPV-2a variants emerged in 2010 ([@bib0145]), and went on to become the major CPV-2 variant in Uruguay in 2011 ([@bib0120]). A recent study reported CPV-2a as the major variant in Columbia ([@bib0080]). In the present study, new CPV-2a was found to be the predominant CPV variant in domestic dogs on the Caribbean island of St. Kitts, contrasting the molecular epidemiology of CPV reported in most studies from North and South American countries.

3.2. Canine enteric coronavirus {#sec0055}
-------------------------------

By RT-PCR targeting a partial fragment of the M protein encoding gene, 5 of the 104 samples tested positive for CCoVs ([Table 1](#tbl0005){ref-type="table"}). Among these sporadic cases, one sample was from an adult dog with mild enteritis, whilst the remaining fecals were from puppies exhibiting mild to severe diarrhea. In the present study, high quality nt sequences of the partial M-protein gene (369 bp, excluding the 5′- and 3′- end primers) could be obtained for 4 of the KNA CCoV strains ([Table 1](#tbl0005){ref-type="table"}).

The partial M-protein gene of the KNA CCoV strains shared 100% nt sequence identities between themselves. With other CCoVs, the partial M protein gene sequences of the KNA CCoV strains shared maximum nt and deduced aa sequence identities of 99% and 100%, respectively, with those of several Brazilian CCoV-I strains. Absolute deduced aa sequence identities were also observed with cognate stretch of reference CCoV-I strain 23/03/ITA. On the other hand, nt and deduced aa identities of \< 91% and \< 94%, respectively, were observed with those of CCoV-II (CCoV-IIa and −IIb) strains. Alignment of partial deduced M protein aa sequences of the KNA CCoV strains with those of CCoV-I, and CCoV-IIa and −IIb strains is shown in supplementary Fig. S3. By phylogenetic analysis of partial M protein genes, the KNA CCoV strains were found to be closely related to CCoV-I strains from Brazil within the CCoV-I cluster, and were distantly related to CCoV-II and feline coronavirus strains ([Fig. 2](#fig0010){ref-type="fig"} ). Based on analysis of partial M-protein gene, the KNA CCoV strains were found to belong to CCoV-I genotype.Fig. 2Phylogenetic tree constructed by the Maximum Likelihood (ML) method from nucleotide sequences of partial M-protein encoding genes (369 bp) of the KNA CCoV strains with those of CCoV-I, CCoV-II, and feline coronavirus (FCoV) strains. The tree was statistically supported by bootstrapping with 1000 replicates, and phylogenetic distances were measured using the Tamura-3-parameter model of substitution. The clustering patterns of KNA CCoV strains were validated by creating ML trees with other mathematical models, such as the Jukes--Cantor model, Kimura 2-parameter model, and Hasegawa--Kishino--Yano model (data not shown). In the tree, the positions of the KNA CCoV strains are shown by dark circles. GenBank accession numbers are shown in parentheses. Bootstrap values \<70% are not shown. Scale bar, 0.05 substitutions per nucleotide.Fig. 2

Whilst the molecular epidemiology of CCoV has been studied in different Asian and European countries ([@bib0020], [@bib0030], [@bib0035], [@bib0065], [@bib0070], [@bib0075], [@bib0085], [@bib0095], [@bib0125], [@bib0140], [@bib0175], [@bib0185]), there is a dearth of data on distribution of CCoV genotypes from the North and South Americas. In Brazil, CCoV-I and CCoV-II strains, including pantropic CCoV-IIa variants were found to be circulating in the domestic dog population ([@bib0025], [@bib0160]). CCoV-IIa and −IIb genotypes have been associated with fatal enteritis in puppies in USA ([@bib0115]). Although CCoVs were detected at lower frequencies in St. Kitts, this is the first report on detection and genotyping of CCoV strains from the Caribbean region.

4. Conclusions {#sec0060}
==============

We reported here the detection and molecular characterization of CPV and CCoV on the Caribbean island of St. Kitts. Although PCR/RT-PCR have been used extensively for detection of CPV/CCoV in many studies including recent reports, these screening assays have been shown to be relatively less sensitive than qPCR/RT-qPCR ([@bib0045], [@bib0050]; [@bib0080]; [@bib0105]; [@bib0130]; [@bib0140]; [@bib0185]). One of the limitation of this study was the use of PCR/RT-PCR as screening assays. However, considering the lack of data from the Caribbean region, the present study primarily focused on detection and molecular characterization of circulating strains rather than strictly monitoring prevalence. New CPV-2a (CPV-2a-297A) was found to be the predominant CPV variant on St. Kitts. CPV-2a has been shown to be the major variant in Asia, whilst CPV-2c, or CPV-2b were predominant in most studies from the North and South Americas ([@bib0130], [@bib0190]). However, the predominance of CPV-2a variants in recent studies from Columbia, Uruguay, and St. Kitts pointed towards the changing epidemiology of CPV in this part of the world. The KNA CCoV strains were genetically closely related to Brazilian CCoV-I strains, which may be attributed to the geographical proximity of the Caribbean region to Latin American countries. Although this is the first report on detection and genetic diversity of CPV and CCoVs from the Caribbean region, the present study was based on a single island. In order to gain vital insights into the molecular epidemiology of these important canine viruses across the entire Caribbean region, similar studies are required in the other islands.

Appendix A. Supplementary data {#sec0070}
==============================

The following are Supplementary data to this article:
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[^1]: Vaccination status against CPV at the time of collection of fecal sample.

[^2]: Refers to a cross between a canine breed that is native to the island of St. Kitts, and another breed.

[^3]: In a recent study, new CPV-2a has also been designated as CPV-2a-297A ([@bib0190]).

[^4]: ORF, Open Reading Frame.

[^5]: Information on exact age not available.

[^6]: Date/s (month-year) of vaccination with VANGUARD Plus 5 L4 (Zoetis, USA).

[^7]: As only small amounts of fecal samples were received from the clinics, it was not possible to obtain the complete ORF sequence of VP2 gene. However, the partial deduced VP2 amino acid sequences of strains PVC18 and PVC21 exhibited 426-N and 555-V, seen in CPV-2a strains.

[^8]: Positions of amino acid residues are based on those of CPV strain CPV-b/USA/1978.

[^9]: The S297A mutation has been found to be fixed in VP2 of recent CPV-2a and CPV-2b strains, and these variants are sometimes designated as new CPV-2a and new CPV-2b strains ([@bib0040], [@bib0130]). In a recent study, new CPV-2a and new CPV-2b strains have also been designated as CPV-2a-297A and CPV-2b-297A, respectively ([@bib0190]).

[^10]: Amino Acid residue 426 of VP2 constitutes the sole basis of differentiating the new CPV-2a (426-N), new CPV-2b (426-D), and CPV-2c (426-E) strains ([@bib0040], [@bib0130]).

[^11]: New CPV-2a strains exhibiting G300D are also referred to as CPV-2a-297A300D ([@bib0190]).
